Rabphilin-3A as a novel target to reverse α-synuclein-induced synaptic loss in Parkinson’s disease

Elena Ferrari(University of Milan), Fabrizio Gardoni(University of Milan)
Pharmacological Research
July 30, 2022
Cited by 27


Related Papers